European Medicines Agency (EMA) is advising marketing authorisation holders to submit type IA and type IAIN variations for 2024 no later than 30th November, 2024. This will enable EMA to acknowledge ...
EMA and the European Commission revise Q&A document on implementation of marketing authorization guidelines. The European Medicines Agency (EMA), in agreement with the European Commission, has ...
The European Medicines Agency (EMA), in agreement with the European Commission, has released an updated question and answer document clarifying a number of issues related to the new categories of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results